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Urticaria, or hives, is a common disease that can 
affect up to 20% of the general population (1). 
Chronic urticaria, defined as urticaria that persists 
for >6 wk, occurs in 0.1% of the population (2), 
and in a significant percentage of cases (40–
80%), there is no identifiable cause (1, 3). H1 
antihistamines have remained the first line of 
treatment because histamine release from cutane-
ous mast cells (MCs) plays an important role in 
the  pathophysiology  of  urticaria  development. 
However, only 55% of patients with chronic 
urticaria are responsive to antihistamines (4), sug-
gesting that in a significant number of individuals, 
chronic urticaria is mediated via histamine-inde-
pendent mechanisms.
An urticarial rash developing in the neonatal 
or early infantile period is one of the clinical man-
ifestations characteristic of cryopyrin-associated 
periodic syndrome (CAPS). CAPS consists of a 
spectrum of hereditary periodic fever disorders 
that comprise three phenotypically overlapping 
but relatively distinct syndromes: familial cold 
autoinflammatory syndrome (Mendelian inheri-
tance in men number [MIM] 120100), Muckle- 
Wells syndrome (MWS; MIM 191900), and 
chronic infantile neurological cutaneous and ar-
ticular syndrome (MIM 607115), which is also 
known as neonatal-onset multisystem inflam-
matory disease. Familial cold autoinflammatory 
syndrome and MWS are characterized by peri-
odic attacks of urticarial rash, fever, and arthralgia, 
whereas patients with chronic infantile neurolog-
ical cutaneous and articular syndrome, the most 
severe form of CAPS, exhibit chronic urticaria as 
well as fever, arthropathy, chronic meningitis, 
papilledema, growth and mental retardation, and 
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Urticarial rash observed in cryopyrin-associated periodic syndrome (CAPS) caused by nucle-
otide-binding oligomerization domain–leucine-rich repeats containing pyrin domain 3 
(NLRP3) mutations is effectively suppressed by anti–interleukin (IL)-1 treatment, suggest-
ing a pathophysiological role of IL-1 in the skin. However, the cellular mechanisms regu-
lating IL-1 production in the skin of CAPS patients remain unclear. We identified mast 
cells (MCs) as the main cell population responsible for IL-1 production in the skin of 
CAPS patients. Unlike normal MCs that required stimulation with proinflammatory stimuli 
for IL-1 production, resident MCs from CAPS patients constitutively produced IL-1. 
Primary MCs expressed inflammasome components and secreted IL-1 via NLRP3 and 
apoptosis-associated speck-like protein containing a caspase recruitment domain when 
stimulated with microbial stimuli known to activate caspase-1. Furthermore, MCs express-
ing disease-associated but not wild-type NLRP3 secreted IL-1 and induced neutrophil 
migration and vascular leakage, the histological hallmarks of urticarial rash, when trans-
planted into mouse skin. Our findings implicate MCs as IL-1 producers in the skin and 
mediators of histamine-independent urticaria through the NLRP3 inflammasome.
© 2009 Nakamura et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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urticarial rash associated with CAPS. Our study identifies resi-
dent MCs in the skin as a cell population capable of producing 
IL-1 via the NLRP3 inflammasome and provides evidence 
that MCs mediate urticarial rash via dysregulated IL-1 produc-
tion in the skin of CAPS patients.
RESULTS
Resident MCs produce constitutively mature IL-1  
in CAPS skin
To identify the source of IL-1 in the human skin, we per-
formed immunolabeling of skin organ cultures with an antibody 
(Ab) that recognizes p17, the mature form of IL-1. Expression 
of mature IL-1 was undetectable in normal skin cells but was 
induced in resident cells by incubation of skin organ cultures 
with LPS and R837 (Fig. 1). In contrast, cells in the dermis of 
two MWS patients harboring the E567K or K355T NLRP3 
mutation and suffering from active disease but not receiving   
any treatment expressed the mature form of IL-1 constitutively 
without any stimulation (Fig. 1). Notably, the majority of 
the mature IL-1–positive cells colocalized with avidin-FITC 
(Fig. 1), which specifically labels tryptase-positive MCs, but not 
with HLA-DR, -DP, -DQ, a marker of DCs and macrophages 
(Fig. S1), in both normal and CAPS skin.
MCs express inflammasome components and produce IL-1 
in response to proinflammatory stimuli
We next analyzed the expression of inflammasome compo-
nents in MCs using mouse bone marrow–derived cultured 
MCs (BMCMCs). The purity of cultured MCs, which was 
>97%, was confirmed by surface expression of CD45 and 
Kit, as well as FITC-avidin labeling. Exclusion of DCs/mac-
rophages was further supported by the lack of I-Ab expression 
in the MC population (Fig. S2 A). BMCMCs constitutively 
expressed Casp1 and the critical adaptor Asc, as determined 
hearing loss (5). The urticarial rash observed in CAPS is similar 
to that associated with common urticaria. However, unlike the 
latter disorder, the rash observed in most CAPS patients responds 
to therapy with IL-1 receptor antagonist rather than antihista-
mines, suggesting that urticaria in these patients is mediated by 
IL-1. However, the cellular mechanism responsible for urticaria 
in CAPS patients remains poorly understood.
The mature form of IL-1 is produced by cleavage of the 
inactive pro–IL-1 precursor by caspase-1, a protease activated 
by a large multiprotein complex termed the inflammasome (6). 
CAPS is caused by missense mutations in the gene, nucleotide-
binding oligomerization domain (NOD)–leucine-rich repeats 
(LRRs) containing pyrin domain 3 (NLRP3) (7), whose prod-
uct is a component of the inflammasome that includes the adap-
tor protein, apoptosis-associated speck-like protein containing a 
caspase recruitment domain (ASC), and procaspase-1 (8, 9). 
NLRP3, a member of the NOD-like receptor family, is an in-
tracellular receptor involved in the recognition of pathogen-
associated molecular patterns (PAMPs). Although several 
microbial activators of NLRP3 have been reported, the precise 
mechanism by which the NLRP3 inflammasome is activated 
by PAMPs remains poorly understood. In the presence of ATP 
or  pore-forming  molecules,  several  PAMPs,  including  LPS, 
muramyl dipeptide, bacterial mRNA, and the antiviral com-
pound R837, activate the NLRP3 inflammasome (10, 11). In 
addition to PAMPs, NLRP3 senses endogenous danger signals 
such as monosodium urate crystals and particulate matter in-
cluding asbestos, silica (12), and aluminum salts (13, 14). Dis-
ease-associated  NLRP3  mutations  associated  with  CAPS 
localize to the centrally located NOD domain and constitu-
tively activate caspase-1 to produce active IL-1 (8, 15). NLRP3 
is predominantly expressed in monocytes, granulocytes, and 
chondrocytes (16, 17), but to date, no reports have investigated 
the cells in the skin that are involved in the development of   
Figure 1.  MCs from the skin of CAPS patients expressing disease-associated NLRP3 mutations constitutively express the mature form of 
IL-1. Human skin specimens were stained with FITC-avidin to label MCs (top) and Alexa Fluor 594–conjugated anti–IL-1 Ab that recognizes only the 
mature form of IL-1 (middle). (bottom) Overlay of fluorescence images of the top and middle panels. The nuclei were counterstained with Hoechst 
33342 (blue). Normal skin represents organ skin cultures with or without incubation with 100 ng/ml LPS or LPS and 100 µM R837 for 24 h. Results are 
representative of at least three separate experiments. Bars, 50 µm.JEM VOL. 206, May 11, 2009 
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immunoblotting (Fig. S2 B), suggesting that R837 promotes 
caspase-1 activation independently of Tlr7 in MCs. In contrast, 
incubation of MCs with LPS alone was sufficient to induce se-
cretion of TNF- and IL-6 (Fig. 2, E and F). Notably, co-stim-
ulation with LPS and R837 did not induce MC degranulation 
as determined by the release of -hexosaminidase (Fig. 2 G) and 
histamine (Fig. 3 A, right), indicating that the mechanisms in-
volved in IL-1 secretion and degranulation are differentially 
regulated in MCs.
ATP stimulation through the purinergic P2X, ligand-gated 
ion channel 7 receptor (P2X7R) is essential for the activation of 
the NLRP3 inflammasome in macrophages (10, 19). We found 
that in addition to R837, ATP induced secretion of IL-1 in 
MCs stimulated with LPS (Fig. 2 D; and Fig. 3 A, left), which 
is consistent with the expression of the P2x7r in MCs (20). K+ 
efflux induced by ATP is important for caspase-1 activation via 
P2x7r (21), and this ion channel rapidly transitions to a pore-like 
structure that allows passage of molecules as large as 900 D (19). 
Notably, IL-1 secretion induced by ATP or R837 was com-
pletely abrogated when the MCs were incubated in medium 
containing a high K+ concentration (Fig. 3 B). Furthermore, 
by RT-PCR analysis (Fig. 2, A and B). In contrast, there was 
no or little expression of Nlrp3 and Il1b in MCs, but both 
genes were induced by stimulation with LPS (Fig. 2, A and B), 
which is consistent with what was reported in human mono-
cytes (18). Induction of Nlrp3 and Il1b by LPS was reduced 
by treatment with MG-132, a broad proteasome inhibitor 
that can affect several signaling pathways including NF-B 
(Fig. 2 A), suggesting that induction of Nlrp3 and Il1b may 
require NF-B activation.
We next determined the ability of MCs to produce IL-1 in 
response to proinflammatory stimuli known to activate caspase-1. 
Stimulation of MCs with LPS alone induced little IL-1 secre-
tion, whereas treatment with R837, a small antiviral synthetic 
compound that activates the NLRP3 inflammasome (11), in-
duced potent IL-1 secretion in MCs pretreated with LPS   
(Fig. 2, C and D). In accordance with these results, R837 effec-
tively induced intracellular processing of pro–IL-1 into p17 in 
LPS-primed MCs, whereas secretion of mature IL-1 into the 
culture supernatant was more potently induced by ATP than by 
R837 (Fig. 2 D). BMCMCs did not express Tlr7 mRNA as as-
sessed by real-time PCR (not depicted) and Tlr7 protein by 
Figure 2.  Activation of inflammasome with LPS and R837 induces IL-1 secretion but not degranulation in MCs. (A) Semiquantitative RT-PCR 
analysis of Nlrp3, Il1b, Asc, Casp1, and Tlr4 in mouse BMCMCs stimulated with 100 ng/ml LPS. 5 µM MG132 was added 30 min before LPS stimulation.  
(B) Expression of specific mRNAs after stimulation for 3 h with 100 ng/ml LPS in BMCMCs was quantified by real-time PCR and normalized to Gapdh expres-
sion (×104). (C) BMCMCs were pretreated with LPS for 15 h and stimulated by R837 for 30 min. IL-1 levels in supernatants were measured by ELISA.  
(D) Immunoblot analysis of cultured supernatant (SN) and cell lysate (CL) from BMCMCs incubated with the indicated stimuli. (E and F) BMCMCs were 
stimulated with 100 ng/ml LPS for 15 h, and the amounts of TNF- and IL-6 in culture supernatants were measured by ELISA. (G) Degranulation of BMCMCs 
was assessed by the release of -hexosaminidase. Error bars represent means ± SD of triplicates. All results are representative of at least three separate 
experiments. *, P < 0.005; and **, P < 0.001 compared with untreated BMCMCs. NS, not stimulated.1040 MCs MEDIATE URTICARIA VIA NLRP3 INFLAMMASOME | Nakamura et al.
IL-1 secretion from MCs depends  
on the Nlrp3 inflammasome
To determine if the inflammasome is required for IL-1 se-
cretion in MCs, we prepared MCs from WT and mutant 
mice deficient in Nlrp3, Nlrc4, or Asc. Stimulation of WT 
and mutant MCs lacking Nlrc4, a NOD-like receptor family 
member involved in inflammasome activation in response to 
flagellin (22, 23), induced processing of procaspase-1 into the 
mature p20 fragment (Fig. 4 A, top). In contrast, production 
of the processed p20 caspase-1 subunit was impaired in MCs 
deficient in Nlrp3 or Asc (Fig. 4 A, middle and bottom). 
Consistently, IL-1 secretion was not detected in MCs from 
Nlrp3- or Asc-deficient mice in response to LPS plus ATP or 
R837 (Fig. 4 B, top), whereas that produced by MCs lacking 
Nlrc4 was unimpaired when compared with WT MCs (Fig. S3, 
top). The lack of IL-1 secretion in MCs deficient in Nlrp3 
or Asc was specific in that production of TNF- and IL-6 
was maintained in WT and mutant MCs (Fig. 4 B, middle 
and bottom; and Fig. S3, middle and bottom), although the 
amounts of both cytokines was reduced in MCs lacking Nlrp3 
(Fig. 4 B, middle and bottom).
We next assessed the expression of inflammasome com-
ponents in other populations of MCs. In mice, MCs are often 
divided into connective tissue– and mucosal-type MCs. 
Mouse fetus skin–derived MCs (FSMCs) are often used as a 
model of connective tissue–type MCs (24) that are distributed 
ATP induced large pore formation in MCs as determined by 
YoPro-1 staining (Fig. 3 C, left), which was not observed in 
P2x7r-deficient MCs (Fig. 3 C, right). Unlike ATP, R837 did 
not induce large pore formation (Fig. 3 C, left) even though 
R837 is structurally related to ATP. However, secretion of 
IL-1 induced by ATP required expression of P2x7r in LPS-
stimulated MCs as well as that elicited by R837 was also depen-
dent, at least in part, on P2x7r (Fig. 3 D). These results suggest 
that the P2x7r and K+ efflux are important for both ATP- and 
R837-induced secretion of IL-1 in MCs.
Figure 3.  IL-1 secretion induced by R837 and ATP is mediated 
via P2x7r and K+ efflux in MCs. (A, left) IL-1 secretion from BMC-
MCs. BMCMCs were cultured with or without LPS for 15 h and then 
stimulated with 5 mM ATP or 100 µM R837. (right) Histamine release 
from BMCMCs was analyzed by ELISA (same samples as in the left 
panel). (B) BMCMCs were cultured with or without LPS for 15 h. Medium 
containing 100 mM KCl or 100 mM NaCl was added for the last 30 min 
of culture at the same time as ATP or R837. IL-1 was measured in cell-
free supernatants. (C) 2 mM YoPro-1 was added 10 min before BMCMCs 
were left untreated (NS) or stimulated with 5 mM ATP or 100 µM R837 
for 30 min, and fluorescence intensity was analyzed by FACS. (D) BMC-
MCs were incubated with the indicated stimuli, and IL-1 was measured 
in cell-free supernatants. Error bars represent means ± SD of triplicates. 
All results are representative of at least three separate experiments. *,  
P < 0.005; **, P < 0.001; and ***, P < 0.0001 compared with untreated 
BMCMCs or between WT and mutant MCs. NS, not stimulated.
Figure 4.  Activation of caspase-1 and IL-1 secretion requires 
the Nlrp3 inflammasome in MCs. (A) Immunoblot analysis of total cell 
extracts and supernatant from BMCMCs. Processing of procaspase-1 
induced by R837 in LPS-primed BMCMCs from WT, Nlrc4-deficient 
(Nlrc4/), Nlrp3-deficient (Nlrp3/), and Asc-deficient (Asc/) mice. 
Cells were pretreated with 100 ng/ml LPS and then stimulated with  
100 µM R837. Casp1, procaspase-1; Casp1 p20, cleaved product of  
caspase-1. (B) Secretion of IL-1, TNF-, and IL-6 by LPS-stimulated  
BMCMCs from the indicated mice in response to R837 or ATP. Error bars 
represent means ± SD of triplicates. All results are representative of at 
least three separate experiments. *, P < 0.005; **, P < 0.001; and ***,  
P < 0.0001 compared between WT and mutant MCs. NS, not stimulated.JEM VOL. 206, May 11, 2009 
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exhibited constitutive Asc-dependent NF-B activation in 
HEK293 cells (Fig. 5 A). To further assess the function of 
disease-associated mutants, we introduced WT and mutant 
Nlrp3 into BMCMCs using a retroviral expression system 
that simultaneously coexpresses GFP. After normalization for 
the number of GFP-expressing cells, we found that the secre-
tion of IL-1 was significantly higher in MCs producing dis-
ease-associated Nlrp3 mutants than in cells expressing WT 
protein after stimulation with LPS (Fig. 5 B). Notably, the 
increased production of IL-1 induced by Nlrp3 mutants 
R258W and Y570C was abolished when their pyrin domain 
was deleted (DPYD_R258W and DPYD_Y570C; Fig. 5 B), 
which is consistent with a critical role for the pyrin domain 
in the interaction with caspase-1 through the adaptor Asc.
To further study the function of disease-associated Nlrp3 
mutant in MCs, we stably expressed WT and the common 
R258W mutant in the MC line MC/9 by retroviral infection 
(Fig. S6). MC/9 cells constitutively expressed Nlrp3, Asc, 
Casp1, and Tlr4 but little or no Il1b in the absence of LPS 
(Fig. 5 C). Expression of Il1b was induced by LPS (Fig. 5 C). 
Importantly, unlike MC/9 cells expressing the CAPS-associ-
ated R258W mutant, cells transduced with control GFP vec-
tor or producing WT-Nlrp3 required stimulation with both 
LPS and ATP or R837, two stimuli that activate the Nlrp3 
in the dermis. We found that the expression of Nlrp3, Asc, 
and Il1b was low in unstimulated FSMCs but enhanced after 
LPS treatment, as it was shown in BMCMCs (Fig. S4 A). 
Similarly, the pattern of IL-1 secretion and MC degranula-
tion was comparable in BMCMCs and FSMCs (Fig. S4,   
B and C). Likewise, human MCs derived from cord blood 
progenitors cultured with stem cell factor expressed ASC, 
NLRP3, and IL1B after LPS stimulation (Fig. S5 A). Similar 
to that reported in human monocytes (25), incubation of 
human MCs with LPS alone was sufficient to induce the pro-
cessing of pro–IL-1 into the mature form of IL-1 (p17), 
which was enhanced by R837 or ATP (Fig. S5, B and C).
Constitutive activation of the inflammasome  
by disease-associated Nlrp3 mutants in MCs
CAPS-associated  NLRP3  mutations  exhibit  constitutive 
ASC-dependent NF-B activation when expressed in tumor 
cell lines (17, 26). To assess the function of mutant NLRP3, 
we generated mouse Nlrp3 mutants (R258W, D301N, and 
Y570C) corresponding to the major CAPS-associated muta-
tions (R260W, D303N, and Y570C, respectively) and tested 
their ability to induce NF-B activation by luciferase reporter 
assay. In agreement with human studies, all three Nlrp3 
mouse mutants as well as the Nlrp3 mutant lacking the LRR 
Figure 5.  Expression of disease-associated Nlrp3 mutants induce constitutive activation of the inflammasome in MCs. (A) Constructs express-
ing WT, mutants (R258W, D301N, and Y570C), or Nlrp3 lacking LRR (∆LRR) were transfected in the presence and absence of Asc plasmid into HEK293 cells. 
NF-B activation was assessed by a dual luciferase reporter assay. Values represent the fold increase over that observed by transfection with control or 
Asc plasmid alone, which was considered as 1. (B) BMCMCs expressing GFP, WT, mutants, and mutants lacking the pyrin (∆PYD_R258W and ∆PYD_Y570C) 
by retroviral infection were stimulated with LPS or left untreated. IL-1 was measured by ELISA and normalized to the number of GFP+ cells, as previously 
described (reference 47). **, P < 0.001; and ***, P < 0.0001 versus LPS-stimulated BMCMCs transfected with WT plasmid. (C) RT-PCR for gene expression in 
MC/9 cells stimulated with LPS. (D) MC/9 cells stably expressing GFP, WT, mutant Nlrp3, or ∆LRR were stimulated with LPS for 15 h, and then stimulated 
with ATP or R837. IL-1 secretions were measured by ELISA. ***, P < 0.0001 versus LPS-stimulated MC/9 cells expressing WT plasmid. Error bars in B and D 
represent means ± SD of triplicates. (E) Immunoblot analysis of culture supernatant (SN) and cell lysate (CL) from MC/9 cells stably expressing WT or 
R258W, and incubated with the indicated stimuli. All results are representative of at least three separate experiments.1042 MCs MEDIATE URTICARIA VIA NLRP3 INFLAMMASOME | Nakamura et al.
Induction of neutrophil-rich inflammation and vascular 
leakage by MCs expressing disease-associated Nlrp3 mutant
Urticarial rash in CAPS skin is characterized histologically by 
the presence of neutrophils and edema in the dermis (27). To 
study the role of IL-1 produced by MCs in vivo, we injected 
MC/9 cells expressing WT or mutant Nlrp3 (R258W) into 
the mouse skin. Histopathological analysis revealed the pres-
ence of neutrophils and edema in the dermis of the mouse ear 
at the site of injection, with MC/9 cells expressing R258W-
Nlrp3 in a pattern that was similar to that observed in the in-
volved skin of human CAPS (Fig. 7 A). In contrast, injection 
with MC/9 cells expressing WT-Nlrp3 induced minimal or no 
neutrophilic infiltrate or edema in the dermis of the mouse ear 
(Fig. 7 A). Furthermore, there was enhanced expression of 
IL-1 in the skin of the ear injected with MC/9 cells expressing 
R258W when compared with that observed with injection of 
MC/9 cells producing WT-Nlrp3 (Fig. 7 B). To determine 
whether the R258W-Nlrp3 mutation promotes vascular leak-
age, a hallmark of urticaria, we injected mice with MC/9 cells 
expressing WT and mutant Nlrp3 (R258W) in the ear skin and 
measured vascular leakage by Evans blue dye. Vascular leakage 
was significantly higher in the skin of mice injected with MC/9 
cells expressing R258W-Nlrp3 than with cells expressing GFP 
alone or WT-Nlrp3 (Fig. 8, A and B). These results indicate 
that MCs expressing disease-associated Nlrp3 promote neutro-
phil recruitment and vascular leakage in the skin, two histolog-
ical hallmarks of urticarial rash associated with CAPS.
DISCUSSION
MCs are widely distributed throughout vascularized tissues, 
where they are located near epithelial surfaces that are ex-
posed to environmental cues, including the skin, airways, and 
gastrointestinal tract (28). MCs are known to promote in-
flammation and tissue remodeling in IgE-associated allergic 
disorders as well as to produce multiple cytokines, including 
IL-1, in response to microbial stimuli, although the mecha-
nisms involved remained unknown (29, 30). In this paper, 
we provide evidence that MCs express components of the 
inflammasome, and these factors are critical for the activation 
of caspase-1 and IL-1 secretion.
Our  analysis  revealed  that  Nlrp3  mutations  associated 
with CAPS induce constitutive activation of the inflamma-
some in MCs, leading to dysregulated IL-1 production in 
the skin. These studies are consistent with a previous report 
that showed enhanced production of IL-1 in the skin of 
CAPS patients (31), although the cellular source of IL-1 
was not investigated by the authors. We showed that transfer 
of MCs expressing the CAPS-associated Nlrp3 mutant in-
duces perivascular neutrophil-rich inflammation in the mouse 
skin, which is the histological hallmark of the urticarial rash 
observed in CAPS patients. Collectively, these studies impli-
cate MCs in inflammasome activation and the pathogenesis 
of IL-1–mediated disease in the skin. Because MCs reside in 
multiples tissues and also participate in experimental models 
of arthritis (32) and encephalomyelitis (33–35), it is possible 
that these cells play a role in disease pathogenesis not only in 
inflammasome, for IL-1 secretion (Fig. 5 D). Although 
stimulation with LPS alone induced the production of pro–
IL-1 in MC/9 cells expressing either WT or mutant Nlrp3, 
the processed p17 form of mature IL-1 could be detected 
only in the culture supernatant of MC/9 cells expressing the 
R258W mutant (Fig. 5 E). In contrast and consistent with 
results presented in Figs. 2–4, the secretion of mature IL-1 
in MC/9 cells expressing WT-Nlrp3 required stimulation 
with both LPS and R837, which was enhanced in cells pro-
ducing the CAPS-associated Nlrp3 mutant (Fig. 5 E).
To assess the effect of disease-associated Nlrp3 in vivo, 
we injected MC/9 cells expressing either WT or mutant 
Nlrp3 i.p. into mice and assessed the recruitment of neutro-
phils in the i.p. cavity. FACS analysis revealed that MC/9 
cells expressing mutant R258W but not WT-Nlrp3 constitu-
tively produced intracellular IL-1 after injection into the 
peritoneal cavity (Fig. 6 A). At 36 h after injection, the num-
ber of Gr-1+ neutrophils was significantly increased in the 
peritoneal cavity of mice injected with MC/9 cells expressing 
mutant R258W-Nlrp3 compared with that found in mice 
injected with cells expressing WT-Nlrp3 (Fig. 6 B). In con-
trast, administration of ionomycin, but not MCs expressing 
WT or mutant Nlrp3, increased the levels of histamine in the 
peritoneal cavity (Fig. 6 C). Collectively, these results indi-
cate that disease-associated Nlrp3 mutants induce constitutive 
production of IL-1 but not histamine release, and promote 
neutrophil recruitment when expressed in MCs.
Figure 6.  MCs expressing disease-associated Nlrp3 mutant pro-
mote neutrophil recruitment but not histamine release in the 
mouse peritoneal cavity. MC/9 cells stably expressing WT or R258W-
Nlrp3 were injected into the mouse peritoneal cavity. Results were ob-
tained 36 h after injection. (A) Shaded histograms represent intracellular 
IL-1 expression in MC/9 cells. The open histogram corresponds to label-
ing with isotype-matched control Ab. (B) Gr-1+ cells in the peritoneal 
fluid. (C) The amounts of histamine in the peritoneal cavity 36 h after 
the injection of MC/9 cells. As a positive control, 1.5 µg ionomycin was 
injected 15 min before sample collection. Error bars represent means ± SD 
of triplicates. All results are representative of at least three separate 
experiments. **, P < 0.001 (n = 5 mice per group).JEM VOL. 206, May 11, 2009 
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with a critical role for that module in the interaction with 
caspase-1 and assembly of the inflammasome (6, 8).
As is the case with macrophages, production of mature 
IL-1 via the Nlrp3/Asc inflammasome in mouse MCs re-
quired two signals, LPS and ATP or R837. Although a main 
function of LPS is to induce pro–IL-1 production, LPS also 
promoted expression of Nlrp3 in MCs, suggesting that LPS 
regulates inflammasome activation via several mechanisms in 
MCs. In macrophages, ATP-driven stimulation through the 
P2x7r is essential for caspase-1 proteolytic cleavage and IL-1 
secretion via Nlrp3 (10, 19). The P2x7r forms a nonselective 
ion channel upon activation with ATP (19) and upon stimu-
lation mediates K+ efflux, which may be important for Nlrp3 
activation (21). This ion channel mediated by P2x7r rapidly 
transitions to a pore-like structure by recruiting the pannexin-1 
pore, which allows passage of molecules as large as 900 D 
(19). Therefore, it is possible, as it has been proposed for mac-
rophages (37), that ATP promotes passage of microbial li-
gands such as LPS via pannexin-1 to trigger inflammasome 
activation in MCs. Consistently, ATP did not induce caspase-1 
activation alone and triggered large pore formation in MCs, 
and this activity was blocked in P2x7r-deficient MCs. Unlike 
ATP, however, R837 did not induce large pore formation 
but elicited IL-1 secretion, at least in part, through P2x7r. 
The role of P2x7r in mediating IL-1 secretion in response 
to R837 stimulation is consistent with the observation that 
high K+ extracellular medium blocked IL-1 secretion in 
MCs. Collectively, these results suggest that ATP and R837 
may promote inflammasome activation via different mecha-
nisms in MCs, although both stimuli require P2x7r and K+ 
efflux for effective IL-1 secretion in MCs.
We observed a reduction in the amounts of TNF- and 
IL-6 produced by MCs lacking Nlrp3 compared with those 
from WT or Asc-deficient cells. The reason for this different 
regulation of cytokine secretion by Nlrp3 and Asc is unclear. 
One possibility is that Nlrp3 contributes to MC maturation in 
an Asc-independent manner. Nlrp3 was first reported as an 
MC maturation–inducible gene (38) whose expression was 
the skin but also in the joints and central nervous system, 
which are also major disease targets in CAPS patients (36). 
Further studies are needed to better understand the contribu-
tion of MCs to IL-1–mediated disease in autoinflammatory 
syndromes associated with NLRP3 mutations.
The mechanism by which NLRP3 mutations cause in-
flammatory diseases is still poorly understood. Studies in vitro 
suggested that these mutations exert a gain-of-function ef-
fect, probably through the loss of a regulatory step associated 
with NLRP3 activation (6, 8). Consistently, mouse Nlrp3 
mutants, corresponding to those observed in human CAPS, 
induced constitutive Asc-dependent NF-B activation and 
IL-1 secretion. Notably, the increased production of IL-1 
induced by CAPS-associated Nlrp3 mutants was abolished 
when their pyrin domain was deleted, which is in accordance 
Figure 7.  MCs expressing disease-associated Nlrp3 mutant induce 
neutrophil-rich inflammation in the mouse skin. 105 MC/9 cells ex-
pressing WT or mutant Nlrp3 (R258W) were injected into the skin of mice. 
(A, top) Representative images of the involved skin from a CAPS patient 
harboring an E567K NLRP3 mutation. (bottom) Cross sections of mouse 
ears 36 h after injection with MC/9 cells. Tissue sections were stained with 
hematoxylin and eosin. Insets show a higher magnification demonstrating 
the presence of numerous neutrophils. Bars, 100 µm. (B) IL-1 expression 
in GFP+ and Nlrp3+ MC/9 cells. (bottom) Immunofluorescence images of 
mouse skin injected with MC/9 cells expressing WT or R258W-Nlrp3. Im-
ages were derived from tissues boxed in the top panels. All results are 
representative of at least three separate experiments. Bars, 50 µm.
Figure 8.  MCs expressing disease-associated Nlrp3 mutant in-
duce vascular leakage in the mouse skin. Vascular leakage was anal-
yzed by intravenous injection of 1% Evans blue solution 36 h after 
injection of mice with MC/9 cells expressing WT and mutant Nlrp3.  
(A, left) Mouse ears 30 min after dye injection. (B) Ears were collected, 
and vascular leakage was determined by absorbance at 620 nm in dye 
tissue extracts. Error bars represent means ± SD of results that are rep-
resentative of at least three separate experiments. *, P < 0.005 between 
WT and R258W (n = 4 or 5 mice per group).1044 MCs MEDIATE URTICARIA VIA NLRP3 INFLAMMASOME | Nakamura et al.
human HLA-DR, -DP, -DQ (TAL.1B5) was purchased from Dako. Anti– 
human tryptase (G3) was provided by L. Schwartz (Virginia Commonwealth 
University, Richmond, VA). Anti–mouse IL-1 was purchased from R&D Sys-
tems. Abs for actin and cryopyrin were purchased from Santa Cruz Biotechnol-
ogy, Inc., Tlr7 was purchased from Imgenex, and I-Ab (clone AF6-120.1) was 
purchased from BD. Anti-GFP was purchased from MBL International, and 
FITC- or Texas red–conjugated avidin was purchased from Invitrogen. Alexa 
Fluor 647–labeled anti–mouse IL-1, Alexa Fluor 647–labeled anti–Ly-6G, and 
PE-labeled anti-CD45 were purchased from eBioscience.
Animals. Nlrp3/, Asc/, Nlrc4/, and P2x7r / mice backcrossed at 
least eight times to C57BL6/J6 mice have been previously described (11, 41, 42). 
C57BL6/J6 mice were purchased from Crea Japan and housed in a patho-
gen-free facility. The animal studies were conducted under approved proto-
cols by the Committee on the Use and Care of Animals of the University of 
Michigan and Chiba University.
Cultured MCs. The preparations of BMCMCs and FSMCs were previ-
ously described (24). The purity of MCs was confirmed by surface expres-
sion of CD45 and Kit, FITC-avidin labeling, and negative I-Ab expression 
(Fig. S2 A). Degranulation of MCs was assessed by -hexosaminidase assay 
as previously described (24). Human MCs from cord blood were cultured as 
previously described (43).
Plasmid construction and retrovirus production. Plasmids to express 
mouse Nlrp3 have been previously described (31). Mutant Nlrp3 constructs 
corresponding to a human disease-associated mutation in the pEF-BOS vector 
were generated as previously described (18, 44). The ability of each construct 
to induce NF-B activation was assessed with mouse Asc plasmid as previously 
described (18, 44). The retrovirus vector pMC-IRES-GFP (provided from 
T. Kitamura, University of Tokyo, Tokyo, Japan) containing Nlrp3 and its 
mutants was produced and introduced into Plat-E packaging cells with 
FuGENE6 (Roche). Immature BMCMCs cultured for 2 wk were incubated 
with retroviral supernatants for 15 h with 10 µg/ml polybrene (Sigma-Aldrich) 
(45). GFP-Nlrp3 fusion proteins were cloned into the pMX-IP vector and 
transfected into Plat-E cells. MC/9 cells were incubated with virus-containing 
supernatants and selected with 1.5 mg/ml puromycin.
Immunohistochemistry. Human and mouse skin biopsy samples were fixed 
with 4% paraformaldehyde, embedded in paraffin, and sectioned. Sections 
were stained with hematoxylin and eosin staining. Immunohistochemical 
staining was performed with primary Abs at the recommended concentrations 
followed by incubation with fluorescent dye–conjugated secondary Abs. Writ-
ten informed consents were obtained from patients, according to the protocol 
of the institutional review board of Kyoto University Hospital and in accor-
dance with the Declaration of Helsinki.
RT-PCR. Total RNA extracted from MCs (2 × 106) with TRIzol reagent 
(Invitrogen) was reverse transcribed and analyzed. The primers were as follows: 
Nlrp3, 5-CACTTGGATCTAGCCACATC-3 and 5-AGCTCCAGCT-
TAAGGGAACTC-3; Asc, 5-ACTTGTCAGGGGATGAACTC-3 and 
5-TGGTACTGTCCTTCAGTCAG-3; Casp1, 5-TACCTGGCAGGA-
ATTCTGGA-3  and  5-ATGATCACCTTGGGCTTGTC-3;  Il1b, 
5-GCTTCCAAACCTTTGACCTG-3 and 5-CTGTTGTTTCCCA-
GGAAGAC-3;  Tlr4,  5-CTGGCATCATCTTCATTGTCC-3  and 
5-GCTTAGCAGCCATGTGTGTTCC-3;  Tlr7,  5-CCACCAGACC-
TCTTGATTCC-3 and 5-TCCAGATGGTTCAGCCTACG-3; Gapdh,   
5-CGGGAAGCTTGTCATCAATGG-3  and  5-GGCAGTGTGATG-
GCATGGATCTG-3; NLRP3, 5-AACAGCCACCTCACTTCCAG-3 
and 5-GACGTAAGGCCAGAATTCAC-3; ASC, 5-TGGTCAGCTTC-
TACCTGGAG-3 and 5-TCCAGGCTGGTGTGAAACTG-3; CASP1, 
5-GTACTTTCTTCCTTTCCAGCTC-3  and  5-TTCACATCTAC-
GCTGTACCC-3;  and  IL1B,  5-TTCACATCTACGCTGTACCC-3 
and 5-GTACTTTCTTCCTTTCCACCTC-3. For real-time analysis, the   
mixture with Power SYBR Green PCR Master Mix (Applied Biosystems) 
increased after the maturation into MCs with a connective 
tissue phenotype. Our BMCMCs were cultured with IL-3 
and stem cell factor, which partially induce connective tis-
sue–type maturation compared with the cells cultured with 
IL-3 alone. This possibility may explain, at least in part, why 
CAPS patients suffered from skin eruption but not asthma 
reaction or rhinitis, even though MCs in these tissues are 
likely to express the constitutively activated disease-associated 
NLRP3 mutation. However, no morphological and func-
tional differences were observed between WT and Nlrp3-de-
ficient MCs. Alternatively, Nlrp3 may directly or indirectly 
regulate cytokine production independently of the inflam-
masome in MCs.
CAPS-associated NLRP3 mutants constitutively produced 
IL-1 in MCs of the skin of patients and when injected into 
mouse tissues. However, it remains unclear why MCs with 
constitutive activation of the NLRP3 inflammasome produce 
mature IL-1 in the absence of LPS in patients given that mi-
crobial stimulation appears to be required for pro–IL-1 pro-
duction. One possibility is that CAPS-associated NLRP3 
mutants induce pro–IL-1 via constitutive activation of NF-
B induction, which is consistent with results found in the 
current work and also reported by others (26). Another possi-
bility is that production of pro–IL-1 is induced by endoge-
nous or environmental cues operating in the skin independently 
of NLRP3. Consistent with this model, the characteristic skin 
rash observed in CAPS and systemic inflammatory syndromes 
often develops within the first few weeks of life when the skin 
is first exposed to environmental factors. These may include 
exposure to small amounts of LPS and/or other microbial 
stimuli after birth. The observation that skin abnormalities in 
incontinentia pigmenti (MIM 308300), an X-linked domi-
nant inherited disorder caused by the mutation of NEMO, a 
gene that encodes the regulatory component of the IB kinase 
complex responsible for the activation of the NF-B signaling 
pathway, commence at birth (39, 40) is also consistent with 
this possibility.
Urticarial rash associated with CAPS is usually nonpruritic 
and unresponsive to antihistamines. This clinical observation 
is in accordance with our observation that NLRP3 inflamma-
some activation induces IL-1 secretion but not degranula-
tion in MCs. Nonetheless, MCs expressing CAPS-associated 
NLRP3 mutant promoted vascular permeability, a cellular re-
sponse also induced by histamine release, which is critical for 
wheal formation in vivo. Because many cases of non-CAPS 
urticaria are unresponsive to histamine receptor antagonists, it 
is possible that skin rash associated with histamine resistance is 
mediated via inflammasome activation in MCs. Thus, under-
standing the pathophysiology of CAPS may provide critical 
insight into more common diseases such as antihistamine- 
refractory urticaria.
MATERIALS AND METHODS
Chemicals and reagents. Ultrapure LPS (Escherichia coli O55:B5), ATP, 
and MG-132 (Z-Leu-Leu-Leu-al) were purchased from Sigma-Aldrich. 
R837 (tlrl-imq) was purchased from InvivoGen. Abs for human cleaved 
IL-1 and IL-1 were purchased from Cell Signaling Technology, and JEM VOL. 206, May 11, 2009 
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was amplified and analyzed with 7300 Real-Time PCR systems (Applied 
Biosystems).
Immunoblotting. Cell extracts were prepared in M-PER reagent (Thermo 
Fisher Scientific) in the presence of protease inhibitor cocktail (Thermo Fisher 
Scientific). Samples were denatured in 2× Laemmli sample buffer (Bio-Rad 
Laboratories) with 1 µl 2-ME. Lysates were separated by SDS-PAGE and trans-
ferred onto membranes (GE Healthcare). Membranes were incubated with an 
Ab against caspase-1, IL-1, GFP, Tlr7, and actin, followed by horseradish per-
oxidase–conjugated Abs. Immunoreactive proteins were visualized with ECL 
detection reagents (GE Healthcare).
Cytokine ELISAs. Supernatants collected from 106 MCs/ml were measured 
for IL-1 (eBioscience), histamine (Invitrogen), TNF-, and IL-6 (R&D Sys-
tems) by ELISA.
Neutrophil migration assay and histamine release. MC/9 cells stably ex-
pressing WT or mutant Nlrp3 (R258W) were suspended in PBS (107 cells/ml) 
and administrated i.p. (0.5 ml/mouse). 36 h after the injection, mice were sacri-
ficed and the peritoneal cavity was lavaged with 2 ml PBS. After gentle massage, 
1 ml of the peritoneal fluid was collected and centrifuged at 500 g for 5 min. Cells 
were stained for FACS analysis and the supernatant was used for histamine assay.
Evans blue dye injection assay. We modified the passive cutaneous anaphy-
laxis assay in mice as previously described (46). Right ears were injected intrader-
mally with 105 cells in 0.1 ml saline and left ears were injected with saline as a 
control; 36 h later, mice were challenged with 0.5 ml saline containing 5 mg/ml 
Evans blue dye. Extravasation of Evans blue dye was monitored for 15 min, and 
ear biopsies were incubated at 63°C overnight in 700 µl formamide. Quantitative 
analysis of extracts was determined by measuring the absorbance at 620 nm.
Statistical analyses. All data are expressed as means ± SD. We accumulated 
the data for each condition from at least three independent experiments. We 
evaluated statistical significance with the Student’s t test for comparisons be-
tween two mean values.
Online supplemental material. Fig. S1 shows the immunochemical stain-
ing of a CAPS patient’s skin where tryptase-positive MCs, but not HLA-DR, 
-DP, -DQ–positive DCs or macrophages, were labeled with avidin and pro-
duced mature IL-1. Fig. S2 shows the purity of BMCMCs and negative pro-
tein expression of Tlr7 on BMCMCs. Fig. S3 shows IL-1, TNF-, and IL-6 
secretion from MCs in WT and Nlrc4-deficient mice. Fig. S4 shows a PCR 
analysis of the inflammasome components in mouse FSMCs that produced 
IL-1, but did not show degranulation, in response to Nlrp3 activator. Fig. S5 
shows a PCR analysis of the inflammasome components in human MCs that 
produced IL-1 in response to Nlrp3 activator. Fig. S6 shows the schematic 
structures of plasmids in pMX-IP retrovirus vector and the purity of MC/9 
stably Nlrp3-GFP–expressing cells that did not show degranulation in response 
to Nlrp3 activator. Online supplemental material is available at http://www 
.jem.org/cgi/content/full/jem.20082179/DC1.
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